geraniin has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; He, B; Li, S; Lu, Y; Shen, Z; Song, B; Yan, H; Yang, R; Yun, Y; Zhang, X; Zhang, Y | 1 |
| Chen, J; He, P; Jiang, L; Liu, S; Liu, Y; Tan, N | 1 |
| Hatano, T; Ishimoto, H; Ito, H; Myojin, Y; Shibata, M; Sugimoto, Y; Tai, A | 1 |
3 other study(ies) available for geraniin and Disease Models, Animal
| Article | Year |
|---|---|
Osteoprotective effect of geraniin against ovariectomy-induced bone loss in rats.
Topics: Alkaline Phosphatase; Animals; Bone Density; Calcitonin; Calcium; Disease Models, Animal; Estradiol; Female; Femur; Glucosides; Hydrolyzable Tannins; Osteoporosis; Ovariectomy; Rats; Rats, Wistar | 2015 |
Geraniin ameliorates cisplatin-induced nephrotoxicity in mice.
Topics: Animals; Cisplatin; Disease Models, Animal; Glucosides; Hydrolyzable Tannins; Kidney; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Renal Insufficiency | 2016 |
In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Discovery; Drug Evaluation, Preclinical; Edema; Free Radical Scavengers; Glucosides; Glucuronides; Humans; Hydrolyzable Tannins; Lythraceae; Mice; Mice, Inbred ICR; Rats | 2011 |